Nanosphere, which markets a platform for molecular diagnostic testing, priced its 7 million share offering at the low end of the $14-$16 range Wednesday evening. Credit Suisse was the bookrunner on the deal. The stock is expected to begin trading Thursday on the...read more
Nanosphere, which develops, manufactures and markets an advanced molecular diagnostics platform, filed terms with the SEC Wednesday for its upcoming IPO. The company plans to offer 7 million shares at a price range of $14 to $16 per share. Credit Suisse is the...read more
Nanosphere, which develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables highly sensitive genomic and protein testing on a single platform, filed for an IPO Monday with the SEC. Credit Suisse is the lead...read more
Top weekly performers: 012 Smile.Communications, Chemspec International, Nanosphere
The following companies were the top performing IPOs over the last five trading sessions:
...read more
Nanosphere prices at low end of range
Nanosphere, which markets a platform for molecular diagnostic testing, priced its 7 million share offering at the low end of the $14-$16 range Wednesday evening. Credit Suisse was the bookrunner on the deal. The stock is expected to begin trading Thursday on the...read more
Molecular diagnostics platform operator Nanosphere announces terms
Nanosphere, which develops, manufactures and markets an advanced molecular diagnostics platform, filed terms with the SEC Wednesday for its upcoming IPO. The company plans to offer 7 million shares at a price range of $14 to $16 per share. Credit Suisse is the...read more
Molecular diagnostics platform operator Nanosphere files for an IPO
Nanosphere, which develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables highly sensitive genomic and protein testing on a single platform, filed for an IPO Monday with the SEC. Credit Suisse is the lead...read more